Zura Bio Announces Two Immunology Abstracts Presented at the World Allergy Congress in Bangkok

Zura Bio Limited , a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders, today announced two abstracts were accepted and...

Related Keywords

Thailand ,Bangkok ,Krung Thep Mahanakhon ,Jackson Cabell ,Someit Sidhu ,Christopher Cabell ,Zura Bio ,Javier Cote Sierra ,Michael Howell ,Brandon Walsh ,World Allergy Congress ,Zura Bio Limited Nasdaq ,Zura Bio Limited ,Chief Scientific Officer ,Translational Science ,Karl Deacon ,Private Securities Litigation Reform Act ,Markets ,